The study of polyethyleneglycol-coated liposomes containing CPT-11

Journal of Liposome Research

Volumn 7, Issue 2-3, 1997, Pages 241-260

  Sadzuka, Yasuyuki ^a   Hirotsu, Sachiyo ^a   Miyagishima, Atsuo ^a   Nozawa, Yasuo ^a   Hirota, Sadao ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IRINOTECAN; LIPOSOME; MACROGOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG FORMULATION; ENCAPSULATION; INTRAVENOUS DRUG ADMINISTRATION; LIPID COMPOSITION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; TISSUE DISTRIBUTION;

EID: 0030798098     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109709035500     Document Type: Article

References (20)

1. Gabizon, A., Goren, D. and Barenholz, Y. 1988. Investigations on the antitumor efficacy of liposome-associated doxorubicin in murine tumor models. Isr. J. Med. Sci. 24 : 512-517.
2. Mayhew, E., Cimino, M., Klemperer, J., Razo, R., Wiernikowski, J. and Arbuck, S. 1990. Free and liposomal doxorubicin treatment of intraperitoneal colon 26 tumor. Therapeutic and pharmacologie studies. Select. Cancer Ther. 6(4) : 193-209.
3. Balazsovits, J. A. E., Mayer, L D., Bally, M. B., Cullis, P. R., Ginsberg, R. S. and Falk, R. E. 1989. Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin. Cancer Chemother. Pharmacol. 23 : 81-86.
4. Sawada, S., Okajima, S., Aiyama, R., Nokota, K., Furuta, T., Yokokura, T., Sugini, E., Yamaguchi, K. and Miyasaka, K. 1991. Synthesis and antitumor activity of 20(s)-camptotecin derivatives. Carbomate-linked, water-soluble derivartives of 7-ethyl-10hydroxy-camptothecin. Chem. Pharm. Bull. 39(6) : 1446-1454.
5. Kawato, Y., Aonuma, M., Hirota, Y., Kuga, H. and Sato, K. 1991. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res. 51(16) : 4187-4191.
6. Tsuji, T., Kaneda, N., Kado, K., Tokokura,.T., Yoshimoto, T. and Tsuru, D. 1991. CPT-11 converting enzyme from rat serum. Purification and some properties. J. Pharmacobiodyn. 14(6) : 341-349.
7. Kawato, Y., Furuta, T., Aonuma, M., Yokokura, T. and Matsumoto, K. 1991. Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice. Cancer Chemother. Pharmacol. 28(3) : 192-198.
8. Kudoh, S., Takada, M., Masuda, N., Nakagawa, K., Itoh, K., Kusunoki, Y., Negri, S., Matsui, K., Takifuji, K., Morino, H. and Fukuoka, M. 1993 Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenografts. Jpn. J. Cancer. Res. 84 : 203-207.
9. Nishimura, G., Satou, T., Yoshimitsu, Y., Kurosaka, Y., Fujimura, T., Sugiyama, K., Kanno, M., Yonemura, Y., Miwa, K. and Miyazaki, I. 1995. Effect of chemotherapy using irinotecan (CPT-11) against recurrent colorectal cancer. Jpn. J. Cancer Chemother. 22(1) : 93-97.
10. Sadzuka, Y., Nakai, S., Miyagishima, A., Nozawa, Y. and Hirota, S. 1995. The effect of dose on the distribution of adriamycin encapsulated in polyethyleneglycol-coated liposomes. J. Drug Targeting 3 : 31-37.
11. Kono, A. and Hara, Y. 1991. Conversion of CPT-11 into SN-38 in human tissues. Jpn. J. Cancer Chemother. 18(12) : 2175-21 78.
12. 2. Barilero, I., Gandia, D., Armand. J. P., Mathien-Bone, A., Re, M., Gouyette, A. and Chabot, G.G. 1992. Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography, application to plasma pharmacokinetics studies in cancer patients. J. Chromatogr. 575 : 275-280
13. Hirotsu, S., Sadzuka, Y., Miyagishima, A., Nozawa, Y. and Hirota, S. 1995. The preparation and the tissue distribution of liposomal CPT-II. Drug Delivery System 10(4) : 283.
14. Taguchi, T., Wakui, A., Hasegawa, K., Niitani, H., Furue, H., Ohta, K. and Hattori, T. 1990. Phase I clinical study of CPT-11. Research group of CPT-11. Jpn. J. Cancer Chemother. 17(1): 115-120.
15. 5. Shimada, K., Miyagishima, A., Sadzuka, Y., Nozawa, Y. Mochizuki, Y., Ohshima, H. and Hirota, S. 1995. Determination of the thickness of the fixed aqueous layer around polyethyleneglycol-coated liposomes. J. Drug Targeting 3 : 283-289.
16. Lopez-Berestein, G., Kasi, L, Rosenblum, M. G., Haynie, T., Jahns, M., Glenn, H., Mehta, R., Mavlight, G. M. and Hersh, E. M. 1984. Distribution and pharmacology of intravenous tecnetium-99mlabeled multilamellar liposomes in rats and mice. Cancer Res. 44 : 375-378.
17. Klibanov, A. L, Maruyama, K., Torchilin, V. P. and Huang, I. 1990. Amphipathic polyethyleneglycols effectively prolong circulation time. FEBS Lett. 268 : 235-237.
18. Allen, T. M. and Chonn, A. 1987. Large unilameller liposomes with low uptake into reticuloendothelial system. FEBS Lett. 223 : 42-46.
19. Mi, Z. and Burke, T. G. 1994. Differential interactions of camptothecin lactone and carboxylate forms with human blood components. Biochemistry 33(34) : 10325-10336.
20. Sasaki, Y., Yoshida, Y., Sudoh, K., Hakusui, H., Fujii, H., Ohtsu, T., Wakita, H., Igarashi, T. and Itoh, K. 1995. Pharmacological correlation between total drug concentration and lactones of CPT-11 and SN-38 in patients treated with CPT-11. Jpn. J. Cancer Res. 86 : 111-116.